During the past decade, Gomel Regional Clinical Oncology Dispensary conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gomel Regional Clinical Oncology Dispensary" #1 sponsor was "Biocad" with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Axelar AB" with 1 trials sponsored, "BeiGene" with 1 trials sponsored and "EirGenix, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gomel Regional Clinical Oncology Dispensary" #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Gomel Regional Clinical Oncology Dispensary" are "Breast Cancer" (2 trials), "Adenocarcinoma of the Lung" (1 trials), "Drug and/or Toxin-induced Diarrhea" (1 trials), "Human Epithelial Receptor (HER)-2 Positive Breast Cancer" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Gomel Regional Clinical Oncology Dispensary" in a lesser frequency.

Most popular intervention types in "Gomel Regional Clinical Oncology Dispensary" are "Drug" (11 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (3 trials), "Placebo" (3 trials), "BCD-100" (2 trials), "Carboplatin" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gomel Regional Clinical Oncology Dispensary" are 8 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Gomel Regional Clinical Oncology Dispensary". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Gomel Regional Clinical Oncology Dispensary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gomel Regional Clinical Oncology Dispensary, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".